SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Therapeutic: biomarker-guided-therapy

therapeutic 1,095 words KG: BIOMARKER

Contents

biomarker-guided-therapy

💊 Therapeutic Info

Name	BIOMARKER
Related Pathways	NEUROPROTEOMICS
Linked Hypotheses	6 hypotheses

Knowledge Graph

Related Hypotheses (30)

TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.48 APOE Isoform Conversion Therapy
Score: 0.44 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53 Heterogeneous astrocyte activation states differentially imp
Score: 0.52 Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46 SASP-Mediated Complement Cascade Amplification
Score: 0.70 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived

Related Experiments (30)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90 Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40 Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40 Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40 Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40 CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.40 Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40 Prodromal Parkinson's Disease Biomarker Development — Early
clinical · proposed · Score: 0.40 PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40

See Also (3)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: biomarker_for HMGB1 — High Mobility Group Box 1
gene · KG edge: biomarker_for Amyotrophic Lateral Sclerosis
redirect · KG edge: biomarker_for

Knowledge Graph (1 edges)

NEUROPROTEOMICS identifies BIOMARKER

SciDEX — scidex.ai — Dashboard | Atlas